References

Conceptualizing the digital thread for smart manufacturing: a systematic literature review

10.1007/s10845-024-02407-1 · 2024 · External reference

Overview of best practices for biopharmaceutical technology transfers

10.5731/pdajpst.2015.01086 · 2015 · External reference

Interoperability levels and challenges of digital twins in cyber–physical systems

10.1016/j.jii.2024.100714 · 2024 · External reference

Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future

10.1016/j.ijpharm.2021.120554 · 2021 · External reference

Opportunities and challenges for model utilization in the biopharmaceutical industry: current versus future state

10.1016/j.coche.2022.100813 · 2022 · External reference

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

10.1038/s41573-023-00670-0 · 2023 · External reference

Exploration and evaluation of modular concepts for the design of full-scale pharmaceutical manufacturing facilities

10.1002/bit.28539 · 2023 · External reference

A resource-based perspective on information technology capability and firm performance: an empirical investigation

10.2307/3250983 · 2000 · External reference

Sysrev: a FAIR platform for data curation and systematic evidence review

10.3389/frai.2021.685298 · 2021 · External reference

10.1007/978-3-319-21569-3

10.1007/978-3-319-21569-3 · 2016 · External reference

Biologics guidances

2025 · External reference

Artificial intelligence and machine learning in software as a medical device

2024 · External reference

Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review

10.3390/pr8091088 · 2020 · External reference

Recent advances in integrated process analytical techniques, modeling, and control strategies to enable continuous biomanufacturing of monoclonal antibodies

10.1002/jctb.6765 · 2022 · External reference

Chapter 26 - the biomanufacturing of biotechnology products

10.1016/b978-0-12-404730-3.00026-9 · 2014 · External reference

Review of AlphaFold 3: transformative advances in drug design and therapeutics

10.7759/cureus.63646 · 2024 · External reference

Unresolved reference

2021 · External reference

Challenges and trends in biopharmaceutical facility design

2024 · External reference

10.1007/978-3-031-42592-9_12

10.1007/978-3-031-42592-9_12 · 2023 · External reference

Gaining agility through IT personnel capabilities: the mediating role of IT infrastructure capabilities

10.17705/1jais.00135 · 2007 · External reference

Development, and translation, board on health sciences policy, and institute of medicine (iom)

2013 · External reference

Unresolved reference

External reference

Personalized medicine: motivation, challenges and progress

10.1016/j.fertnstert.2018.05.006 · 2018 · External reference

The resource-based theory of competitive advantage: implications for strategy formulation

10.1016/b978-0-7506-7088-3.50004-8 · 1991 · External reference

Prospering in dynamically-competitive environments: organizational capability as knowledge integration

10.1287/orsc.7.4.375 · 1996 · External reference

Unresolved reference

2019 · External reference

Harvesting the benefits of LEAN in biopharmaceutical manufacturing

2009 · External reference

Cost advantages of single-use technologies

2010 · External reference

Exploring the value of AI technology in optimizing and implementing supply chain data for pharmaceutical companies

2023 · External reference

MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information [Supporting Information]

10.1021/acs.jcim.3c00799 · 2024 · External reference

Enabling technologies for personalized and precision medicine

10.1016/j.tibtech.2019.12.021 · 2020 · External reference

A reliable automated sampling system for On-Line and real-time monitoring of CHO cultures

10.3390/pr8060637 · 2020 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Automation

2021 · External reference

Recent innovations in adaptive trial designs: a review of design opportunities in translational research

10.1017/cts.2023.537 · 2023 · External reference

Therapeutic gene editing is here, can regulations keep up?

10.38105/spr.czm9c2w8ig · 2020 · External reference

Progress in biopharmaceutical development

10.1002/bab.1617 · 2018 · External reference

Accelerating biomanufacturing by modeling of continuous bioprocessing—piloting case study of monoclonal antibody manufacturing

10.3390/pr7080495 · 2019 · External reference

Unresolved reference

External reference

Understanding data, information, knowledge and their inter-relationships

2007 · External reference

Unresolved reference

2010 · External reference

Comprehensive manipulation of glycosylation profiles across development scales

10.1080/19420862.2018.1527665 · 2019 · External reference

AI on drugs: can artificial intelligence accelerate drug development? Evidence from a large-scale examination of bio-pharma firms

10.2139/ssrn.3524985 · 2021 · External reference

Understanding the link between information technology capability and organizational agility: an empirical examination

10.2307/41409967 · 2011 · External reference

Pharmacovigilance: reporting requirements throughout a product’s lifecycle

10.1177/20420986221125006 · 2022 · External reference

Benchmark glycan profile of therapeutic monoclonal antibodies produced by Mammalian cell expression systems

10.1007/s11095-023-03628-4 · 2023 · External reference

Personalized medicine could transform healthcare

10.3892/br.2017.922 · 2017 · External reference

Vaccine innovation model: a technology transfer perspective in pandemic contexts

10.1016/j.vaccine.2022.06.054 · 2022 · External reference

Unresolved reference

1995 · External reference

Big data analytics capabilities: a systematic literature review and research agenda

10.1007/s10257-017-0362-y · 2018 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Continuous manufacturing of recombinant drugs: comprehensive analysis of cost reduction strategies, regulatory pathways, and global implementation

10.3390/ph18081157 · 2025 · External reference

Advances in bioreactor control for production of biotherapeutic products

10.1002/bit.28346 · 2023 · External reference

Enhancing biopharmaceutical supply chains: strategies for efficient drug formulary development in emerging markets

10.54660/ijmbhr.2022.3.1.73-82 · 2022 · External reference

Unresolved reference

External reference

About model validation in bioprocessing

10.3390/pr9060961 · 2021 · External reference

Bioprocess control: current progress and future perspectives

10.3390/life11060557 · 2021 · External reference

Effect of information systems resources and capabilities on firm performance: a resource-based perspective

10.1080/07421222.2005.11045820 · 2005 · External reference

A new theoretical understanding of big data analytics capabilities in organizations: a thematic analysis

10.1186/s40537-021-00543-6 · 2021 · External reference

Emerging challenges and opportunities in pharmaceutical manufacturing and distribution

10.3390/pr9030457 · 2021 · External reference

Modeling comes of age in biopharma

2019 · External reference

Single-use disposable technologies for biopharmaceutical manufacturing

10.1016/j.tibtech.2012.10.004 · 2013 · External reference

Capacity planning for batch and perfusion bioprocesses across multiple biopharmaceutical facilities

10.1002/btpr.1860 · 2014 · External reference

Integrated product and manufacturing system platforms supporting the design of personalized medicines

10.1016/j.jmsy.2020.06.016 · 2020 · External reference

Decision making and risk management in biopharmaceutical engineering—opportunities in the age of Covid-19 and digitalization

10.1021/acs.iecr.0c02994 · 2020 · External reference

10.1007/978-3-031-46452-2

10.1007/978-3-031-46452-2 · 2024 · External reference

Data science tools and applications on the way to pharma 4.0

10.1016/j.drudis.2019.06.005 · 2019 · External reference

Small labels, big challenges: solutions for advanced therapy labeling

10.18609/cgti.2020.128 · 2020 · External reference

Why 90% of clinical drug development fails and how to improve it?

10.1016/j.apsb.2022.02.002 · 2022 · External reference

Biopharmaceutical manufacturing: historical perspectives and future directions

10.1146/annurev-chembioeng-092220-125832 · 2022 · External reference

IS capabilities, supply chain collaboration and quality performance in services: the moderating effect of environmental dynamism

10.1108/imds-08-2021-0496 · 2022 · External reference

Unresolved reference

2018 · External reference

Unresolved reference

2022 · External reference

Chapter 4 - scale up of biopharmaceuticals production

10.1016/b978-0-12-813629-4.00004-8 · 2018 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Unresolved reference

External reference

Managing the innovation supply chain to maximize personalized medicine

10.1038/clpt.2013.228 · 2014 · External reference

Harnessing the potential of machine learning for advancing “Quality by Design” in biomanufacturing

10.1080/19420862.2021.2013593 · 2022 · External reference

Unresolved reference

2009 · External reference

Unresolved reference

2024 · External reference

Current state of implementation of in silico tools in the biopharmaceutical industry—Proceedings of the 5th modeling workshop

10.1002/bit.28768 · 2024 · External reference

Prediction of biopharmaceutical facility fit issues using decision tree analysis

2013 · External reference

Pharmacovigilance in cell and gene therapy: evolving challenges in risk management and long-term Follow-Up

10.1007/s40264-025-01596-9 · 2025 · External reference

Machine learning with domain knowledge for predictive quality monitoring in resistance spot welding

10.1007/s10845-021-01892-y · 2022 · External reference